CytCut Alpha Testing Yields Overwhelmingly Positive Results

The future of cell migration research is here! Early alpha testing of CytCut (formerly CellCut), our innovative tool for 2D scratch assays, has received overwhelmingly positive feedback from two partner labs. Specifically designed to standardize cell migration studies, CytCut is set to transform how researchers evaluate the healing abilities of cells.

Why CytCut Stands Out

During testing, CytCut was used on 48-well plate samples, producing uniform and identical scratches across all wells in a single step. The benefits of this breakthrough device include:

• Standardized Data: CytCut eliminates human variability, ensuring consistent, reproducible results for cell migration and wound-healing studies.

• Reduced Waste: Unlike traditional pipette tip methods, CytCut is reusable and easy to sterilize, minimizing material waste and saving costs.

• Rapid Application: While traditional methods take up to 10 minutes, CytCut completes the same task in under 1 minute, drastically improving workflow efficiency.

Our partner labs praised the device’s precision, speed, and ability to deliver high-quality, reliable data, marking it as a game-changer for life science research.

Exciting News: The First-Client Initiative

As we move forward, we are excited to announce CytCut will be available under our "First-Client Initiative" program allowing approved partners to use CytCut for an entire year at no cost. This initiative reflects our commitment to supporting researchers and accelerating innovation in the field of life sciences.

The Future of 2D Scratch Assays

CytCut is not just a tool; it’s a step forward in simplifying, optimizing, and enhancing cell migration assays. By merging efficiency, sustainability, and precision, we are enabling researchers to push boundaries and accelerate discoveries in cell biology and wound-healing research. Stay tuned for more updates as CytCut enters its next phase. If you’re interested in joining the First-Client Initiative, contact us today and be part of this groundbreaking innovation.